Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells

2021 ◽  
Author(s):  
M Lehmann ◽  
K Allers ◽  
C Heldt ◽  
F Schmidt ◽  
Y Rodriguez-Sillke ◽  
...  
2016 ◽  
Vol 34 (4_suppl) ◽  
pp. 233-233
Author(s):  
Chanjuan Shi ◽  
Ramya Thota ◽  
Jordan Berlin

233 Background: The programmed death 1 (PD-1) pathway is up-regulated in the immune microenvironment of many cancers. PD-1 blockage has been shown to be effective in treating some malignancies. In colorectal cancers, inhibition of PD-1 pathway appears to be selectively efficacious in microsatellite instable (MSI) tumors. In this study, we examined the immune microenvironment of small intestinal adenocarcinoma by immunohistochemistry. Methods: Twenty two small intestinal adenocarcinomas were identified from our Pathology Archives from 01/01/2002 to 05/01/2014. Immunohistochemical studies were employed to evaluate expression of CD3, CD4, CD8, CD20, CD56, PD-1 and programmed death ligand 1 (PD-L1). CD3+, CD4+, and CD8+ T cells were estimated under high power fields (HPF) and compared between PD-L1+ and PD-L1- tumors. Results: The 22 cases included 9 females and 13 males, with age ranging from 38 to 92 years. PD-1 was expressed in 18 of 22 (82%) cases, by tumor surrounding lymphocytes and lymphoid aggregates as well as tumor infiltrating lymphocytes if present. PD-L1 expression was observed in 10 of 22 (45%) cases, including 2 MSI, 2 microsatellite stable (MSS) and 6 tumors with unknown MSI status. PD-L1 was mainly expressed by histiocytes capping cancerous glands/nests at the infiltrating front. Expression of PD-L1 was also seen in tumor cells surrounding by the histiocytic caps. All the 10 cancers also expressed PD-1. The tumors expressing PD-L1 contained more CD3+ (440±22/HPF versus 238±31/HPF, p < 0.01), CD4+ (172±26/HPF versus 287±25/HPF, p < 0.01) and CD8+ T cells (58±17/HPF versus 153±33/HPF, p = 0.013) than those without expression of PD-L1. CD20+ cells were mainly seen in lymphoid aggregates. There were rare or none C56+ inflammatory cells. Conclusions: PD-1 and PD-L1 are expressed by inflammatory cells (mainly histiocytes) and tumors cells in most small intestinal adenocarcinoma. Blockage of the PD-1 pathway should be evaluated in the treatment of small intestinal adenocarcinomas.


2009 ◽  
Vol 131 ◽  
pp. S112-S113
Author(s):  
Daisuke Fujiwara ◽  
Bo Wei ◽  
Jonathan Braun
Keyword(s):  
T Cells ◽  

Author(s):  
Manuel Reithofer ◽  
Sandra Rosskopf ◽  
Judith Leitner ◽  
Claire Battin ◽  
Barbara Bohle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document